✦ LIBER ✦

Diabetes drugs and neurological disorders: new views and therapeutic possibilities

✍ Scribed by Patrone, Cesare; Eriksson, Ove; Lindholm, Dan

Book ID: 123323077
Publisher: Elsevier
Year: 2014
Tongue: English
Weight: 461 KB
Volume: 2
Category: Article
ISSN: 2213-8587
DOI: 10.1016/S2213-8587(13)70125-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Developing New Drugs for Diabetes and Ca

Developing New Drugs for Diabetes and Cardiometabolic Disorders

✍ Professor Andrew J. Krentz, Linda Morrow, Marcus Hompesch 📂 Article 📅 2012 🏛 Springer International Publishing AG 🌐 English ⚖ 91 KB

PDE7 inhibitors as new drugs for neurolo

PDE7 inhibitors as new drugs for neurological and inflammatory disorders

✍ Gil, Carmen; Campillo, Nuria E; Perez, Daniel I; Martinez, Ana 📂 Article 📅 2008 🏛 Informa plc 🌐 English ⚖ 510 KB

A ubiquitous membrane fusion protein αSN

A ubiquitous membrane fusion protein αSNAP: a potential therapeutic target for cancer, diabetes and neurological disorders?

✍ Andreeva, Alexandra V; Kutuzov, Mikhail A; Voyno-Yasenetskaya, Tatyana A 📂 Article 📅 2006 🏛 Informa plc 🌐 English ⚖ 180 KB

Nanoparticle iron chelators: A new thera

Nanoparticle iron chelators: A new therapeutic approach in Alzheimer disease and other neurologic disorders associated with trace metal imbalance

✍ Gang Liu; Ping Men; Peggy L.R. Harris; Raj K. Rolston; George Perry; Mark A. Smi 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 281 KB

Multiple genetic and epigenetic interact

Multiple genetic and epigenetic interacting mechanisms contribute to clonally selection of drug-resistant tumors: Current views and new therapeutic prospective

✍ Annalisa Roberti; Dario La Sala; Caterina Cinti 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 266 KB

## Abstract Successful treatment of cancer requires a clear understanding of drug‐resistance mechanism. Cancer patient are often treated with standard protocols without considering individual difference in chemosensitivity, whereas the efficacy of anticancer drug varies widely among individual pati

Blockade of receptor for advanced glycat

Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disorders

✍ Barry I Hudson; Loredana G Bucciarelli; Thoralf Wendt; Taichi Sakaguchi; Evanthi 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 245 KB